BBramley
TL3 Regular · Strasbourg, FR
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 28 December 2024 · last posted just now
145 posts, newest first. Showing up to 150.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #48 · Clinical › Bloodwork · 28 Jul 2026 · 0 likes I would put moderate confidence on the mainstream reading of egfr fluctuation and no more. That is not scepticism for its own sake; it is where the sourcing actually…
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #23 · Clinical › Bloodwork · 27 Jul 2026 · 27 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #85 · Practice › Dosing & titration · 21 Jul 2026 · 29 likes Building on post #84 rather than restating it. Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is…
-
Common supplements people ask about, assessed one at a time Replied, post #73 · Practice › Interactions · 20 Jul 2026 · 28 likes Post #70 is the version of this I will quote in future. One addition. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #52 · Clinical › Prescriber conversations · 19 Jul 2026 · 18 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. The reasoning is more useful…
-
Journal club: what we got wrong in an earlier session Replied, post #97 · Evidence › Journal club · 18 Jul 2026 · 0 likes On post #96 — agreed on the reasoning, with one qualification. Reading order that works for these sessions: registry entry, methods, baseline table, primary result,…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #111 · Devices › Syringes & needles · 18 Jul 2026 · 13 likes A methods point on 0.3 ml versus 0.5 ml rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #85 · Meta › Announcements · 18 Jul 2026 · 8 likes Where the Trust level 3 requirements reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #71 · Compounds › Retatrutide · 18 Jul 2026 · 3 likes Coming back to post #69, because the follow-up matters more than the original answer. Retatrutide discussion is a good example of a question where the honest answer is…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #29 · Practice › Interactions · 15 Jul 2026 · 29 likes Post #25 describes the usual case. This is about the unusual one. Practical note on Delayed gastric emptying and oral: write down what you expect before you look. The…
-
Pooling trials with different estimands Replied, post #99 · Evidence › Meta-analyses · 15 Jul 2026 · 5 likes Adding what did not work for me on pooling trials with different estimands, since the failures never get written up and they are half the useful information.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #15 · Access › Insurance & coverage · 10 Jul 2026 · 3 likes Everything in post #13 holds. The case it does not cover is the one I have. The version of Prior authorisation that circulates here is a simplification of a…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #9 · Practice › Interactions · 9 Jul 2026 · 6 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Tracking a shortage from primary sources rather than rumour Replied, post #92 · Access › Shortages · 9 Jul 2026 · 10 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum…
-
Restarting after a long gap: what the labelling implies Replied, post #16 · Practice › Dosing & titration · 8 Jul 2026 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Prescription requirements and telehealth models — a second dataset Replied, post #95 · Sourcing › Regulatory · 7 Jul 2026 · 2 likes The most useful reply I ever got about Prescription requirements and telehealth models was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #54 · Compounds › Repair & healing peptides · 5 Jul 2026 · 1 like Helpful, and short, which on this subject is harder than long.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #22 · Evidence › Journal club · 4 Jul 2026 · 11 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Prescription portability between countries Replied, post #79 · Access › International · 28 Jun 2026 · 0 likes Taking post #78 at face value and following it one step further. Reciprocal recognition between regulators exists in some regions and not others, and assuming it is how…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #33 · Outcomes › Body composition · 27 Jun 2026 · 26 likes Reading back through the ultrasound and skinfolds threads from last year, the same three questions come up every time and only one of them has ever been answered…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #85 · Safety › Contraindications · 24 Jun 2026 · 8 likes Confirming post #84 from a second method, which matters more than confirming it from a second person. Allergy to the specific compound: true allergy is rare but…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #15 · Pharmacology › Receptor biology · 11 Jun 2026 · 0 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
Packaging that arrived damaged: documenting it properly Replied, post #21 · Sourcing › Logistics · 7 Jun 2026 · 0 likes I read post #17 twice before replying, because I had assumed the opposite. Import restrictions by jurisdiction: what is legal to import for personal use varies…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #36 · Evidence › Journal club · 7 Jun 2026 · 6 likes Picking up post #33: that is the part I would want checked first. The baseline characteristics table is the single most useful page for the questions that get asked…
-
Reading a trial's population section before its results Replied, post #95 · Evidence › Trials · 6 Jun 2026 · 12 likes Where I part company with post #91, and it is a narrow parting. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive…
-
Forced degradation studies: designing one that is informative Replied, post #70 · Analytics › Method validation · 5 Jun 2026 · 9 likes On post #68 — agreed on the reasoning, with one qualification. I think the forced degradation studies question is answerable and has not been answered, which is a more…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #20 · Pharmacology › Pharmacokinetics · 31 May 2026 · 9 likes My position on peak-to-trough ratio is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #4 · Evidence › Meta-analyses · 6 May 2026 · 6 likes On post #2 — agreed on the reasoning, with one qualification. On Risk-of-bias tools, the part that usually goes wrong is that the question is asked as though it has one…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #23 · Compounds › Tirzepatide · 5 May 2026 · 27 likes On storage: published stability data covers the licensed formulation at its licensed concentration. A research preparation reconstituted at home in a different diluent…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #130 · Pharmacology › Pharmacokinetics · 5 May 2026 · 2 likes Adding the measurement that post #127 says would settle it. Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration…
-
A fridge failure and how I assessed the contents afterwards Replied, post #9 · Devices › Cold chain · 2 May 2026 · 0 likes Reading this fridge failure thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
GLP-1 receptor distribution: central and peripheral — one year on Replied, post #10 · Pharmacology › Receptor biology · 17 Apr 2026 · 0 likes Building on post #8 rather than restating it. Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #26 · Practice › Interactions · 14 Apr 2026 · 0 likes Adding a small correction to the widely repeated interaction claim summary above rather than a disagreement with it. The substance holds; one of the figures is out by a…
-
Follow-up: State-level differences that actually matter Replied, post #91 · Regional › North America · 8 Apr 2026 · 13 likes Thank you for taking the time. That was more work than a reply usually is.
-
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #12 · Pharmacology › Formulation chemistry · 5 Apr 2026 · 0 likes Coming back to post #8, because the follow-up matters more than the original answer. Since Lyophilisation keeps coming up, it should probably be a maintained page…
-
Journal club: is percentage weight change the right endpoint? Replied, post #39 · Evidence › Journal club · 4 Apr 2026 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. Stating my…
-
The "under review" status pill and when a moderator applies it Replied, post #52 · Evidence › Preprints · 3 Apr 2026 · 15 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Preprint servers and what screening they do Replied, post #101 · Evidence › Preprints · 24 Mar 2026 · 30 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #11 · Analytics › Mass spectrometry · 22 Mar 2026 · 6 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #58 · Practice › Interactions · 21 Mar 2026 · 5 likes Small correction to my own earlier position on anaesthesia and elective surgery. I had the units the wrong way round, which changes the conclusion by an order of…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #130 · Practice › Interactions · 11 Mar 2026 · 22 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #69 · Clinical › Special populations · 11 Mar 2026 · 31 likes Adding the measurement that post #66 says would settle it. The thing about pregnancy and pregnancy planning that took me longest to accept is that a plausible mechanism…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #2 · Analytics › Mass spectrometry · 10 Mar 2026 · 2 likes Helpful, and short, which on this subject is harder than long.
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #4 · Evidence › Journal club · 7 Mar 2026 · 2 likes Confirming post #3 from a second method, which matters more than confirming it from a second person. The figures usually contain the finding and the text usually…
-
Validating a calculator against hand arithmetic Replied, post #9 · marked as the solution · Data & Tools › Calculators · 3 Mar 2026 · 7 likes Everything in post #5 holds. The case it does not cover is the one I have. Validating a calculator against hand: I would want to see the raw numbers rather than the…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #139 · Analytics › COA interpretation · 24 Feb 2026 · 3 likes Post #135 describes the usual case. This is about the unusual one. A certificate is a statement by its issuer that a defined test was performed on a defined lot and…
-
MHRA statements, read directly Replied, post #92 · Regional › UK & Ireland · 19 Feb 2026 · 0 likes Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have changed and the old ones are still circulating. That is one dataset…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #23 · Practice › Dosing & titration · 16 Feb 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #84 · Documentation › Wiki requests · 12 Feb 2026 · 17 likes Post #82 answers the question as asked. The question underneath it is different. Translation suggestions: if a maintained page should exist in another language,…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #18 · Practice › Administration · 8 Feb 2026 · 0 likes Post #14 put the caveat in the right place and I want to underline it. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from…
-
Reading an interaction checker output critically Replied, post #113 · Practice › Interactions · 7 Feb 2026 · 22 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Foaming during reconstitution and whether it matters — the long version Replied, post #21 · Practice › Reconstitution · 30 Jan 2026 · 12 likes Coming back to post #19, because the follow-up matters more than the original answer. Taking Foaming during reconstitution seriously for a moment rather than…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #27 · Pharmacology › Pharmacokinetics · 29 Jan 2026 · 0 likes Taking post #26 at face value and following it one step further. The version of Washout that I was taught turned out to be a teaching simplification. Useful, and not…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #64 · Access › Pricing · 17 Jan 2026 · 15 likes Practical answer on Price changes, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
-
Journal club: semaglutide in MASH, and surrogate endpoints — does this still hold? Replied, post #2 · Evidence › Journal club · 2 Jan 2026 · 28 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #51 · Compounds › Semaglutide · 2 Jan 2026 · 12 likes Counterpoint on semaglutide solutions, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #31 · Access › International · 29 Dec 2025 · 10 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #3 · Practice › Administration · 24 Dec 2025 · 25 likes Worth separating two things that the opening post runs together. One more thing on Rotating between abdomen that took me far too long to see: the two figures people…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 24 Dec 2025 · 0 likes Worth separating two things that post #13 runs together. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #36 · Analytics › Method validation · 24 Dec 2025 · 31 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. Correct me on the arithmetic if it…
-
Meeting a protein target on a suppressed appetite Replied, post #42 · Nutrition & Training › Protein & intake · 14 Dec 2025 · 13 likes Taking post #39 at face value and following it one step further. Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #36 · Pharmacology › Pharmacokinetics · 12 Dec 2025 · 0 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #52 · Compounds › Tirzepatide · 7 Dec 2025 · 0 likes Where I have landed on Tirzepatide in type 2 diabetes, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
-
Tracking a preprint to publication: a worked example Replied, post #58 · Evidence › Preprints · 6 Dec 2025 · 0 likes Nothing to add, except that this is the answer I would give if asked.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #60 · Practice › Reconstitution · 25 Nov 2025 · 9 likes Helpful, and short, which on this subject is harder than long.
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #38 · Analytics › Impurities & related substances · 21 Nov 2025 · 5 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #47 · Compounds › Semaglutide · 14 Nov 2025 · 33 likes I would rather this thread reach "we do not know" about semaglutide half-life than reach a confident answer that nobody can support when asked.
-
Follow-up: Why appetite effects are mostly central Replied, post #91 · Pharmacology › Receptor biology · 9 Nov 2025 · 0 likes Where a mechanism is proposed to explain an effect, the useful follow-up is what observation would distinguish it from the alternative. Most mechanistic threads here…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #13 · Sourcing › Regulatory · 18 Oct 2025 · 20 likes This follows post #12 rather than contradicting it. Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims…
-
Sleep quality changes during weight loss — what changed since Replied, post #28 · Wellbeing › Sleep · 16 Oct 2025 · 13 likes Post #26 is right about the mechanism and I think understates the practical bit. Eating patterns shift substantially and late intake affects sleep independently of…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #79 · Practice › Reconstitution · 15 Oct 2025 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
What a purity-only report leaves out Replied, post #47 · Sourcing › Independent verification · 15 Oct 2025 · 0 likes The arithmetic in post #44 is right; the assumption feeding it is the part to check. For anyone finding this later: the short answer on purity-only is that it depends…
-
New subcategory: rationale and scope Replied, post #16 · Meta › Announcements · 13 Oct 2025 · 13 likes The most useful thing anyone has posted about new subcategory in this category was a table of what had been measured and by whom. That is what I would want again.
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #102 · Analytics › HPLC & UHPLC · 10 Oct 2025 · 32 likes Adding a data point of agreement rather than a data point.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #137 · Practice › Reconstitution · 3 Oct 2025 · 0 likes My experience of 10 mg vial reconstituted three contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #148 · Practice › Storage & stability · 23 Sep 2025 · 4 likes On published stability data actually covers, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #27 · Data & Tools › Datasets · 7 Sep 2025 · 9 likes A dataset is only useful if the collection method is described alongside it. Numbers without a protocol are a list rather than data. The claim is narrower than it…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #82 · Evidence › Journal club · 6 Sep 2025 · 21 likes If you are new and reading this thread for the answer to orforglipron phase 2: the answer is conditional, the conditions are in the third reply, and the rest of the…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #67 · Evidence › Journal club · 1 Sep 2025 · 2 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
A ten-fold dose error caught before injection Replied, post #90 · Devices › Syringes & needles · 28 Aug 2025 · 18 likes Since ten-fold dose error caught keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #12 · Analytics › Method validation · 23 Aug 2025 · 0 likes Post #9 is the version of this I will quote in future. One addition. The most useful single question about a method: what would it fail to detect? Every method has an…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #2 · Compounds › Tirzepatide · 23 Aug 2025 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #118 · Compounds › Semaglutide · 13 Aug 2025 · 1 like On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #21 · Evidence › Journal club · 12 Aug 2025 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Someone will…
-
Travel coolers and how long they really hold Replied, post #73 · Devices › Cold chain · 7 Aug 2025 · 23 likes Travel coolers has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
How to research a compound with no human data without deceiving yourself Replied, post #9 · Compounds › Other compounds · 30 Jul 2025 · 16 likes Picking up post #6: that is the part I would want checked first. I would put moderate confidence on the mainstream reading of research a compound and no more. That is…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #14 · Analytics › Method validation · 21 Jul 2025 · 8 likes Reporting a result to more decimal places than the method's precision supports is a small dishonesty that appears everywhere. A method with a two per cent relative…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2025 · 10 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Foaming during reconstitution and whether it matters Replied, post #19 · Practice › Reconstitution · 11 Jul 2025 · 25 likes Noted, and thank you for writing it out rather than summarising it.
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #19 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2025 · 20 likes Comparing an amylin analogue to an incretin agonist on weight change alone misses that they were developed to be used together rather than instead of each other. The…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #6 · Start Here › Welcome · 25 Jun 2025 · 5 likes Seconded. It reads as careful rather than confident, which is the right register.
-
State-level differences that actually matter Replied, post #6 · Regional › North America · 22 Jun 2025 · 8 likes Prior authorisation criteria are usually published by the payer and reading them before the appointment changes the outcome more than anything else does. This is where…
-
Antibiotics and a course of something with delayed emptying Replied, post #68 · Practice › Interactions · 18 Jun 2025 · 9 likes Delayed gastric emptying is the mechanism behind most of the plausible interactions in this class: anything whose absorption depends on how quickly the stomach empties…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #64 · Access › Insurance & coverage · 11 Jun 2025 · 11 likes Saving this. It is the version I will quote when the question comes round again.
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #33 · Evidence › Journal club · 10 Jun 2025 · 0 likes The arithmetic in post #31 is right; the assumption feeding it is the part to check. The figures usually contain the finding and the text usually contains the…
-
Appeal templates and why they are deliberately unemotional Replied, post #4 · Access › Insurance & coverage · 7 Jun 2025 · 19 likes Everything in post #2 holds. The case it does not cover is the one I have. Formulary status: the list of covered medications and the tier (how much you pay) they are…
-
A report I filed that turned out to be wrong, and the correction Replied, post #72 · Sourcing › Vendor reports · 27 May 2025 · 0 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. I would rather say I do…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #156 · Sourcing › Regulatory · 19 May 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Pregnancy as an absolute contraindication Replied, post #52 · Safety › Contraindications · 19 May 2025 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed pregnancy, as opposed to read about it? The thread is long and I cannot tell.
-
DXA precision and the least significant change for lean mass — the long version Replied, post #44 · Outcomes › Body composition · 15 May 2025 · 9 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure. I…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #56 · Data & Tools › Calculators · 8 May 2025 · 12 likes Validating a calculator against hand was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #127 · Documentation › Doc review · 27 Apr 2025 · 11 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything.
-
Dizziness on standing: the ordinary explanation first Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 26 Apr 2025 · 8 likes Taking post #13 at face value and following it one step further. On dizziness on standing the community has more anecdote than the confidence in this thread implies,…
-
Follow-up: What other technical communities get right that we do not Replied, post #74 · Lounge › Off topic · 21 Apr 2025 · 2 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page. One of those cases where…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #23 · Data & Tools › Calculators · 19 Apr 2025 · 3 likes Building on post #22 rather than restating it. Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within…
-
Sequence verification for an obscure compound: how it is done Replied, post #8 · Compounds › Other compounds · 8 Apr 2025 · 5 likes Research use only, not approved for human use, and in this subcategory the compounds vary enormously in how much is known about them. It is worth establishing which end…
-
Counter-ion content and its effect on measured mass Replied, post #12 · Analytics › Mass spectrometry · 6 Apr 2025 · 1 like Confirming post #10 from a second method, which matters more than confirming it from a second person. Mass accuracy is expressed in parts per million. It is the…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #15 · Practice › Administration · 30 Mar 2025 · 0 likes Site reactions that appear immediately and settle within a day are described commonly here. Ones that appear a day later and spread are a different observation and…
-
Validating a method you did not develop — does this still hold? Replied, post #143 · Analytics › Method validation · 20 Mar 2025 · 14 likes Linearity across the working range is a routine demonstration and it constrains how far a result can be extrapolated. A method linear from 80 to 120 per cent of nominal…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #100 · Analytics › COA interpretation · 19 Mar 2025 · 0 likes A stability statement tied to a named storage condition can be evaluated. One without a condition attached cannot be evaluated at all and is decoration.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #142 · Sourcing › Vendor reports · 19 Mar 2025 · 9 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. One of those cases where knowing the mechanism does…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #32 · Sourcing › Vendor reports · 15 Mar 2025 · 20 likes A difference inside method repeatability is not a disagreement. Saying so in your own report prevents somebody else reading it as one. Noting that the question and the…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #6 · Devices › Syringes & needles · 15 Mar 2025 · 17 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #99 · Compounds › Semaglutide · 13 Mar 2025 · 0 likes The practical version of published dose-response for semaglutide is three sentences long. The rigorous version is three pages and reaches the same conclusion with the…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #100 · Data & Tools › Calculators · 22 Feb 2025 · 5 likes I had written a reply contradicting post #98 and deleted it. Here is what survived. Titration planning: a calculator that shows you the escalation schedule for…
-
Follow-up: Attributing a new peak: degradation product or excipient? Replied, post #3 · Analytics › Impurities & related substances · 14 Feb 2025 · 4 likes On the opening post — agreed on the reasoning, with one qualification. Where I have landed on Attributing a new peak, having got it wrong once in public: the direction…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #5 · Compounds › Semaglutide · 6 Feb 2025 · 14 likes That is a fair summary of where the discussion has got to.
-
A page that has drifted out of date and needs a maintainer Replied, post #59 · Documentation › Wiki requests · 2 Feb 2025 · 29 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change. Stating my assumptions rather…
-
Scheduled maintenance and what will be unavailable Replied, post #22 · Meta › Announcements · 23 Jan 2025 · 7 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #17 · Practice › Reconstitution · 21 Jan 2025 · 18 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Isotonicity and what happens when you get it wrong Replied, post #28 · Pharmacology › Formulation chemistry · 14 Jan 2025 · 7 likes Post #27 put the caveat in the right place and I want to underline it. Marking my uncertainty on isotonicity explicitly. I am confident about the direction, much less…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #36 · Compounds › Oral incretins · 10 Jan 2025 · 28 likes I had written a reply contradicting post #34 and deleted it. Here is what survived. Why administration conditions matter for oral semaglutide and not for injectables:…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #30 · Safety › Adverse events · 21 Dec 2024 · 0 likes The arithmetic in post #29 is right; the assumption feeding it is the part to check. Pancreatitis is a genuine serious adverse event to know: severe epigastric pain,…
-
Building a sensible monitoring schedule with your prescriber Replied, post #50 · Clinical › Bloodwork · 20 Dec 2024 · 0 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. A partial answer, offered because a partial…
-
Coming back to: When to suspect the method rather than the sample Replied, post #99 · Analytics › Method validation · 19 Dec 2024 · 0 likes Building on post #98 rather than restating it. Linearity across the working range is a routine demonstration and it constrains how far a result can be extrapolated. A…
-
Body image changing more slowly than the body Replied, post #24 · Wellbeing › Mental health · 13 Dec 2024 · 1 like Post #23 is right about the mechanism and I think understates the practical bit. Body image sits at the boundary between what this community can usefully discuss and…
-
What we do not know about retatrutide, listed explicitly Replied, post #17 · Compounds › Retatrutide · 10 Dec 2024 · 1 like Picking up post #16: that is the part I would want checked first. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is…
-
Washout with a one-week half-life: the arithmetic Replied, post #85 · Research Methods › N-of-1 designs · 7 Dec 2024 · 0 likes Everything in post #81 holds. The case it does not cover is the one I have. Generalisability: a robust n-of-1 result applies to you. It does not tell you much about…
-
Why "any advice?" is the least effective ending for a post Replied, post #64 · Start Here › How to Ask · 23 Nov 2024 · 0 likes Chromatography questions need the method before anything else: column, gradient, wavelength, injection volume. A purity figure with no method attached cannot be…
-
EMA product information as a primary source — does this still hold? Replied, post #146 · Regional › European Union · 19 Nov 2024 · 0 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #6 · Analytics › Mass spectrometry · 13 Nov 2024 · 8 likes Deamidation adds approximately one dalton and produces a species that frequently elutes very close to the parent. It is the hardest common impurity to see…
-
Time to steady state after a dose increase Replied, post #41 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 8 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability.
-
When "no data" is the complete and final answer Replied, post #10 · Compounds › Other compounds · 27 Oct 2024 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Second pass at: Reimbursement variation across member states Replied, post #23 · Regional › European Union · 23 Oct 2024 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #12 · Analytics › Impurities & related substances · 18 Oct 2024 · 11 likes Thank you for the correction. I would rather find out here than later.
-
Blind submission and why it changes minds Replied, post #77 · Sourcing › Independent verification · 3 Oct 2024 · 2 likes Post #74 is right about the mechanism and I think understates the practical bit. I would call the community position on blind submission likely rather than established,…
-
Identical chromatograms across two different lots Replied, post #32 · Sourcing › Red flags · 3 Oct 2024 · 1 like Everything in post #30 holds. The case it does not cover is the one I have. A definition problem is doing most of the work in this identical chromatograms discussion.…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #103 · Sourcing › Independent verification · 2 Oct 2024 · 7 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #36 · Evidence › Journal club · 6 Sep 2024 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Promotion criteria, and the one that stops most nominations Replied, post #51 · Documentation › Doc review · 1 Sep 2024 · 0 likes The arithmetic in post #48 is right; the assumption feeding it is the part to check. Something worth flagging about promotion criteria: the strongest-sounding claims in…
-
Correlation in a self-tracked dataset: what it can support Replied, post #50 · Research Methods › Statistics · 22 Aug 2024 · 8 likes I would keep correlation and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why…
-
Circumference measurements as a poor man's composition estimate Replied, post #67 · Outcomes › Body composition · 14 Aug 2024 · 0 likes Where the circumference measurements reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #96 · Practice › Dosing & titration · 9 Jul 2024 · 30 likes The arithmetic in post #94 is right; the assumption feeding it is the part to check. Going back down a step is not a failure and the trials allowed it. Several…
-
[2026 update] Comparing tirzepatide and semaglutide is harder than the tables suggest Started this topic · Compounds › Tirzepatide · 8 Jun 2024 · 11 likes Comparing tirzepatide and semaglutide is harder than the tables suggest Writing it up because I had to work it out twice and would rather nobody else did. Putting the…
-
Assessing a warm arrival: the decision process — one year on Replied, post #127 · Sourcing › Logistics · 2 Jun 2024 · 0 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…